A critical breakthrough in cancer study is arising with the use of mini-antibodies to re-engage damaged p53. This crucial malignant suppressor protein is frequently disabled in several types of cancer, causing https://businessbookmark.com/story7562649/nanobodies-restore-the-p53-protein-a-potential-hope-for-malignant-treatment